Chengxi Liu

Chengxi Liu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2024 in Behavioural Brain Research
Verified
Journal Article
Open access
LZLeguang Zhou
Leguang Zhou
HSHongzhao Shi
Hongzhao Shi
MXMengzhe Xiao
Mengzhe Xiao
WLWenjie Liu
Wenjie Liu
LWLijuan Wang
Lijuan Wang
CLChengxi Liu
Chengxi Liu
Remimazolam, a novel benzodiazepine, is widely used as an anesthetic in endoscopic procedures; however, its effects on cognitive function remain unclear, limiting its broader application in general anaesthesia. Neuroinflammation is a well-established key factor in the etiology and progression of cognitive dysfunction, including conditions such as Alzheimer's disease, Parkinson's disease, postoperative delirium, and postoperative cognitive dysfunction. Preclinical studies have demonstrated that remimazolam exerts anti-inflammatory and neuroprotective effects, and clinical reports indicate a reduced incidence of postoperative delirium in patients treated with remimazolam. Nevertheless, whether remimazolam improves cognitive function through its anti-inflammatory properties remains uncertain. This study aimed to investigate the neuroprotective effects of remimazolam and its underlying mechanism in a lipopolysaccharide (LPS)-induced model of neuroinflammation, neuronal injury, and cognitive dysfunction METHODS: C57BL/6 J male mice were administered LPS intraperitoneally to establish a model of neuroinflammation-induced cognitive impairment. A subset of mice received remimazolam via intraperitoneal injection 30 minutes prior to LPS administration. Cognitive performance was evaluated using behavioural tests, including the Morris Water Maze (MWM), Novel Object Recognition (NOR) test, and Open Field Test (OFT). Hippocampal tissues were analyzed by haematoxylin-eosin (HE) staining to assess structural changes. Inflammatory markers, including Interleukin (IL)-6, IL-1β, and tumor necrosis factor-α, were quantified using enzyme-linked immunosorbent assay (ELISA) and real-time quantitative PCR. Immunofluorescence was used to detect translocator protein (TSPO) and markers of microglia activation (IBA-1, CD16/32, and CD206). (1) Remimazolam reversed LPS-induced cognitive deficits, as evidenced by shorter spatial exploration latency and increased platform crossings in the MWM, and an elevated recognition index in the NOR test. (2) Remimazolam improved hippocampal morphology, reducing LPS-induced neuronal damage. (3) Remimazolam significantly decreased levels of hippocampal inflammatory cytokines, inhibited microglial activation, promoted M2-type microglia polarization, and increased TSPO expression. Remimazolam demonstrated neuroprotective and anti-neuroinflammatory effects in a mouse model of LPS-induced cognitive impairment. These effects are likely mediated through the regulation of TSPO, which inhibits microglial activation and promotes the polarization of microglia from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype.

8 March 2021 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
YZYi Zhang
Yi Zhang
HGHuan Gui
Huan Gui
ZDZikun Duan
Zikun Duan
TYTian Yu
Tian Yu
JZJie Zhang
Jie Zhang
CLChengxi Liu
Chengxi Liu

31 January 2023 in The FASEB Journal
Verified
Journal Article
Open access
JYJianyin Yin
Jianyin Yin
JQJie Qin
Jie Qin
ZLZhaojing Lin
Zhaojing Lin
ALAiyuan Li
Aiyuan Li
DLDamin Liu
Damin Liu
CLChengxi Liu
Chengxi Liu
The glutamatergic–mediated excitatory system in the brain is vital for the regulation of sleep–wake and general anesthesia. Specifically, the paraventricular hypothalamic nucleus (PVH), which contains mainly glutamatergic neurons, has been shown to play a critical role in sleep–wake. Here, we sought to explore whether the PVH glutamatergic neurons have an important effect on the process of general anesthesia. We used c‐fos staining and in vivo calcium signal recording to observe the activity changes of the PVH glutamatergic neurons during isoflurane anesthesia and found that both c‐fos expression in the PVH and the calcium activity of PVH glutamatergic neurons decreased in isoflurane anesthesia and significantly increased during the recovery process. Chemogenetic activation of PVH glutamatergic neurons prolonged induction time and shortened emergence time from anesthesia by decreasing the depth of anesthesia. Using chemogenetic inhibition of PVH glutamatergic neurons under isoflurane anesthesia, we found that inhibition of PVH glutamatergic neurons facilitated the induction process and delayed the emergence accompanied by deepening the depth of anesthesia. Together, these results identify a crucial role for PVH glutamatergic neurons in modulating isoflurane anesthesia.

23 January 2026 in JCI Insight
Verified
Journal Article
Open access
PDF file
LYLin Yang
Lin Yang
CLChengxi Liu
Chengxi Liu
JXJin Xiao
Jin Xiao
YSYu Song
Yu Song
HCHuan Chen
Huan Chen
LQLintao Qu
Lintao Qu
Acute severe joint pain is a major symptom in gouty arthritis (GA), and its adequate treatment represents an unmet medical need. Mrgprb2, a specific mast cell receptor, has been implicated in the generation of chronic pain by mobilizing mast cell degranulation, yet its significance in GA pain and joint inflammation is still not well defined. Here, we found that Mrgprb2 was expressed in mouse synovial mast cells. In a murine model of GA, acute blockade or genetic deletion of Mrgprb2 significantly attenuated arthritis pain and hyperexcitability of joint nociceptors with significant reductions in innate immune cell recruitment in the synovium. Under naive conditions, activation of synovial Mrgprb2 was sufficient to excite peripheral terminals of joint nociceptors to induce acute joint hypernociception via the mobilization of mast cell degranulation. Additionally, the level of the neuropeptide substance P (SP) was elevated in the synovium of GA model mice. Using humanized MRGPRX2-knockin mice, we revealed that SP contributed to joint pain and inflammation by activating mast cells through Mrgprb2/MRGPRX2. These findings suggest that synovial mast cell–expressed Mrgprb2/MRGPRX2 merits consideration as a key neuroimmune player and a potential therapeutic target for treating GA pain and joint inflammation.

27 May 2026 in Metabolism Open
Verified
Journal Article
Open access
DKDeyu Kong
Deyu Kong
YLYang Long
Yang Long
THTingting Huang
Tingting Huang
YZYonghu Zhang
Yonghu Zhang
WLWenjie Liu
Wenjie Liu
SLShan Liu
Shan Liu
Dysglycemia is common in critically ill patients and is associated with adverse outcomes, but the prognostic significance of early ICU glycemic patterns remains unclear. In this dual-database cohort study, 60,365 critically ill patients from MIMIC-IV were used for model development and 81,237 from eICU for external validation. Early blood glucose trajectories were clustered using dynamic time warping (DTW). Associations with mortality were assessed using survival and multivariable regression analyses. Least Absolute Shrinkage and Selection Operator (LASSO)-selected predictors were incorporated into machine-learning models, which were externally validated and interpreted using SHapley Additive exPlanations (SHAP). Four glycemic trajectory phenotypes were identified in both cohorts. A rising stress hyperglycemia-like trajectory was consistently associated with the highest mortality risk. In MIMIC-IV, this phenotype was associated with higher in-hospital, 180-day, and 1-year mortality; in eICU, it was also associated with the highest in-hospital mortality. Machine-learning models integrating trajectory phenotype with other clinical variables outperformed Simplified Acute Physiology Score II (SAPS II) and Oxford Acute Severity of Illness Score (OASIS). Random Forest was selected as the representative model, and a web-based tool was developed for individualized risk estimation. A rising stress hyperglycemia-like phenotype identifies a high-risk subgroup of critically ill patients and may improve mortality risk stratification beyond conventional severity scores.